FCM
Farallon Capital Management Portfolio holdings
AUM
$21.3B
This Quarter Return
+9.47%
1 Year Return
+23.12%
3 Year Return
+87.19%
5 Year Return
+183.94%
10 Year Return
+836.54%
AUM
$14.3B
AUM Growth
+$14.3B
(+18%)
Cap. Flow
+$1.65B
Cap. Flow
% of AUM
11.55%
Top 10 Holdings %
Top 10 Hldgs %
53.52%
Holding
113
New
19
Increased
34
Reduced
32
Closed
9
Top Buys
| 1 |
APC
Anadarko Petroleum
APC
|
$738M |
| 2 |
CELG
Celgene Corp
CELG
|
$648M |
| 3 |
WCG
Wellcare Health Plans, Inc.
WCG
|
$475M |
| 4 |
RHT
Red Hat Inc
RHT
|
$339M |
| 5 |
AGN
Allergan plc
AGN
|
$167M |
Top Sells
| 1 |
TransUnion
TRU
|
$194M |
| 2 |
Meta Platforms (Facebook)
META
|
$179M |
| 3 |
Booking.com
BKNG
|
$164M |
| 4 |
Alphabet (Google) Class C
GOOG
|
$162M |
| 5 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
$159M |
Sector Composition
| 1 | Healthcare | 35.75% |
| 2 | Technology | 18.98% |
| 3 | Communication Services | 14.38% |
| 4 | Industrials | 7.19% |
| 5 | Consumer Discretionary | 4.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AGN
26
DELISTED
Allergan plc
AGN
| $167M | 1.09% |
+1,000,000
| New | +$167M |
|
27
Cigna
CI
$80.1B
| $165M | 1.08% |
1,050,000
+105,000
| +11% | +$16.5M |
|
|
28
Alphabet (Google) Class C
GOOG
$2.78T
| $154M | 1% |
142,223
-150,105
| -51% | -$162M |
|
29
Iovance Biotherapeutics
IOVA
$789M
| $140M | 0.91% |
5,725,000
| – | – |
|
|
30
TransUnion
TRU
$16.8B
| $123M | 0.8% |
1,672,343
-2,645,503
| -61% | -$194M |
|
31
Sea Limited
SE
$107B
| $112M | 0.73% |
3,375,000
-3,545,000
| -51% | -$118M |
|
|
MRTX
32
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $102M | 0.67% |
995,000
-205,000
| -17% | -$21.1M |
|
|
MYOK
33
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $100M | 0.65% |
2,000,000
+49,722
| +3% | +$2.49M |
|
|
XLRN
34
DELISTED
Acceleron Pharma Inc.
XLRN
| $97.6M | 0.63% |
2,375,000
| – | – |
|
35
Liberty Global Class C
LBTYK
$4.08B
| $97.5M | 0.63% |
3,675,974
-632,132
| -15% | -$16.8M |
|
|
ZGNX
36
DELISTED
Zogenix, Inc.
ZGNX
| $95.6M | 0.62% |
2,000,000
-50,500
| -2% | -$2.41M |
|
|
ZAYO
37
DELISTED
Zayo Group Holdings, Inc.
ZAYO
| $92.8M | 0.6% |
+2,820,000
| New | +$92.8M |
|
|
SAGE
38
DELISTED
Sage Therapeutics
SAGE
| $91.5M | 0.6% |
500,000
-100,000
| -17% | -$18.3M |
|
39
Alibaba
BABA
$325B
| $84.7M | 0.55% |
500,000
+85,000
| +20% | +$14.4M |
|
|
AMRN
40
Amarin Corp
AMRN
$310M
| $82.4M | 0.54% |
4,250,000
+1,000,000
| +31% | +$19.4M |
|
41
Enanta Pharmaceuticals
ENTA
$191M
| $81M | 0.53% |
960,000
+20,000
| +2% | +$1.69M |
|
42
Alnylam Pharmaceuticals
ALNY
$58.7B
| $79.8M | 0.52% |
1,100,000
+600,000
| +120% | +$43.5M |
|
|
ONCE
43
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $78.8M | 0.51% |
770,000
-50,000
| -6% | -$5.12M |
|
|
GWR
44
DELISTED
Genesee & Wyoming Inc.
GWR
| $77.5M | 0.5% |
+775,000
| New | +$77.5M |
|
45
FibroGen
FGEN
$48.3M
| $76.8M | 0.5% |
1,700,000
+784,421
| +86% | +$35.4M |
|
46
Sarepta Therapeutics
SRPT
$1.98B
| $76M | 0.49% |
500,000
-150,000
| -23% | -$22.8M |
|
47
NovoCure
NVCR
$1.33B
| $75.9M | 0.49% |
1,200,000
+150,000
| +14% | +$9.48M |
|
|
RETA
48
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $75.5M | 0.49% |
800,000
+50,000
| +7% | +$4.72M |
|
|
S
49
DELISTED
Sprint Corporation
S
| $70.1M | 0.46% |
10,675,000
+9,085,000
| +571% | +$59.7M |
|
50
Grifois
GRFS
$6.53B
| $65M | 0.42% |
3,080,083
+153,731
| +5% | +$3.24M |
|